The International Journal of Tuberculosis and Lung Disease

Chronic respiratory disease: the forgotten NCD?
pp. 1261-1261(1)
Authors: Marks, Guy B.; Billo, Nils E.

Preventive chemotherapy for contacts of MDR-TB: is the proof in the pudding?
pp. 1262-1263(2)
Authors: Lange, Christoph; Kampmann, Beate

The role of biomarkers in the management of airways disease
pp. 1264-1268(5)
Authors: Baines, K. J.; Pavord, I. D.; Gibson, P. G.

Global burden of asthma among children
pp. 1269-1278(10)
Authors: Asher, I.; Pearce, N.

Respiratory effects in children from passive smoking of cigarettes and narghile: ISAAC Phase Three in Syria
pp. 1279-1284(6)
Authors: Mohammad, Y.; Shaaban, R.; Hassan, M.; Yassine, F.; Mohammad, S.; Tessier, J. F.; Ellwood, P.

Cigarette smoking among tuberculosis patients increases risk of transmission to child contacts
pp. 1285-1291(7)
Authors: Huang, C-C.; Tchetgen, E. Tchetgen; Becerra, M. C.; Cohen, T.; Galea, J.; Calderon, R.; Yataco, R.; Contreras, C.; Zhang, Z-B.; Lecca, L.; Murray, M.

Children exposed to multidrug-resistant tuberculosis at a home-based day care centre: a contact investigation
pp. 1292-1298(7)
Authors: Garcia-Prats, A. J.; Zimri, K.; Mramba, Z.; Schaaf, H. S.; Hesseling, A. C.

Identifying multidrug resistance in previously treated tuberculosis patients: a mixed-methods study in Cambodia
pp. 1299-1306(8)
Authors: Royce, S.; Khann, S.; Yadav, R. P.; Mao, E. T.; Cattamanchi, A.; Sam, S.; Handley, M. A.

Geographic predictors of primary multidrug-resistant tuberculosis cases in an endemic area of Lima, Peru
pp. 1307-1314(8)
Authors: Shah, L.; Choi, H. W.; Berrang-Ford, L.; Henostroza, G.; Krapp, F.; Zamudio, C.; Heymann, S. J.; Kaufman, J. S.; Ciampi, A.; Seas, C.; Gotuzzo, E.; Brewer, T. F.

Initial experience of bedaquiline use in a series of drug-resistant tuberculosis patients from India
pp. 1315-1318(4)
Authors: Udwadia, Z. F.; Amale, R. A.; Mullerpattan, J. B.

The disconnect between a national tuberculosis drug resistance survey and treatment outcomes: a lost opportunity
pp. 1319-1322(4)
Authors: Click, E. S.; Chirenda, J.; Kibias, S.; Menzies, H. J.; Oeltmann, J. E.; Sentle, C.; Muribe, T.; Lere, T. D.; Makombe, R.; Bamrah, S.; Moore, B. K.; Cain, K. P.

What is the role for Xpert^® MTB/RIF in high-resource settings? Experience from a central London hospital
pp. 1323-1326(4)
Authors: Gupta, R. K.; Lawn, S. D.; Booth, H.; Morris-Jones, S.

Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries
pp. 1327-1336(10)
Authors: Ballif, M.; Nhandu, V.; Wood, R.; Dusingize, J. C.; Carter, E. J.; Cortes, C. P.; McGowan, C. C.; Diero, L.; Graber, C.; Renner, L.; Hawerlander, D.; Kiertiburanakul, S.; Du, Q. T.; Sterling, T. R.; Egger, M.; Fenner, L.; for the International epidemiological Databases to Evaluate AIDS (IeDEA)

Elevated hepcidin at HIV diagnosis is associated with incident tuberculosis in a retrospective cohort study
pp. 1337-1339(3)
Authors: Minchella, P. A.; Armitage, A. E.; Darboe, B.; Jallow, M. W.; Drakesmith, H.; Jaye, A.; Prentice, A. M.; McDermid, J. M.

Impact of three empirical anti-tuberculosis treatment strategies for people initiating antiretroviral therapy
pp. 1340-1346(7)
Authors: Van Rie, A.; Westreich, D.; Sanne, I.

Longevity loss among cured tuberculosis patients and the potential value of prevention
pp. 1347-1352(6)
Authors: Hoger, S.; Lykens, K.; Beavers, S. F.; Katz, D.; Miller, T. L.

Extending tuberculosis notification to the private sector in India: programmatic challenges?
pp. 1353-1356(4)
Authors: Nagaraja, S. B.; Achanta, S.; Kumar, A. M. V.; Satyanarayana, S.

Estimated incidence of tuberculosis by capture-recapture in the Balearic Islands, 2010–2012
pp. 1357-1362(6)
Authors: Giménez-Duran, J.; Galmés-Truyols, A.; González-Cortijo, T.; Bosch-Isabel, C.; Nicolau-Riutort, A.; de Mateo-Ontañón, S.

Role of adenosine deaminase and the influence of age on the diagnosis of pleural tuberculosis
pp. 1363-1369(7)
Authors: Abrao, F. C.; de Abreu, I. R. L. Bruno; Miyaki, D. H.; Busico, M. A. M.; Younes, R. N.

The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: a systematic review
pp. 1370-1377(8)
Authors: Brode, S. K.; Daley, C. L.; Marras, T. K.

Association of surfactant protein B gene with chronic obstructive pulmonary disease susceptibility
pp. 1378-1384(7)
Authors: Yang, J.; Wang, B.; Zhou, H-X.; Liang, B-M.; Chen, H.; Ma, C-L.; Xiao, J.; Deng, J.; Yan, L.; Chen, Y-P.; Chen, C-L.; Chen, F.; Ou, X-M.; Feng, Y-L.

Changes in QT intervals after azithromycin-containing antibiotic therapy in patients with NTM lung disease
pp. 1385-1385(1)
Authors: Shin, Beomsu; Park, Hye Yun; Koh, Won-Jung

Cost-effectiveness of 12-dose LTBI regimen improved following advocacy to lower the price of rifapentine
pp. 1386-1386(1)
Authors: Frick, Mike; Seaworth, Barbara; McKenna, Lindsay; Elnour, Taharqa; Lee, Cynthia